Published in Pain on February 01, 2000
Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun (2006) 2.00
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immun (2006) 1.67
Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Mol Pain (2005) 1.66
Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol Rev (2011) 1.66
"Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids. Brain Res Rev (2007) 1.62
Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Exp Neurol (2008) 1.46
HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Mol Pain (2006) 1.32
Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling. Pain (2010) 1.17
Bilateral changes of TNF-alpha and IL-10 protein in the lumbar and cervical dorsal root ganglia following a unilateral chronic constriction injury of the sciatic nerve. J Neuroinflammation (2010) 1.14
Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: the effects of interleukin-10 and glial inhibitors. Mol Pain (2009) 1.08
Interleukin-6 mediates low-threshold mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120. Brain Behav Immun (2007) 1.02
Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse. Gut (2006) 0.99
Reciprocal regulation of nuclear factor kappa B and its inhibitor ZAS3 after peripheral nerve injury. BMC Neurosci (2006) 0.95
Role of NFkappaB in an animal model of complex regional pain syndrome-type I (CRPS-I). J Pain (2009) 0.94
The biochemical origin of pain--proposing a new law of pain: the origin of all pain is inflammation and the inflammatory response. Part 1 of 3--a unifying law of pain. Med Hypotheses (2007) 0.91
Systemic inflammation decreases pain threshold in humans in vivo. PLoS One (2013) 0.89
N-Methyl-D-aspartate receptor (NMDAR) independent maintenance of inflammatory pain. Pain (2009) 0.89
PEGylation of interleukin-10 for the mitigation of enhanced pain states. J Biomed Mater Res A (2010) 0.88
IL-10 cytokine released from M2 macrophages is crucial for analgesic and anti-inflammatory effects of acupuncture in a model of inflammatory muscle pain. Mol Neurobiol (2014) 0.88
Spinal interleukin-10 therapy to treat peripheral neuropathic pain. Neuromodulation (2012) 0.88
Caspase-1 modulates incisional sensitization and inflammation. Anesthesiology (2010) 0.88
Upregulation of cystathionine beta-synthetase expression by nuclear factor-kappa B activation contributes to visceral hypersensitivity in adult rats with neonatal maternal deprivation. Mol Pain (2012) 0.86
Characterization of NF-kB-mediated inhibition of catechol-O-methyltransferase. Mol Pain (2009) 0.85
Regular physical activity prevents chronic pain by altering resident muscle macrophage phenotype and increasing interleukin-10 in mice. Pain (2016) 0.83
Gabapentin enhances the morphine anti-nociceptive effect in neuropathic pain via the interleukin-10-heme oxygenase-1 signalling pathway in rats. J Mol Neurosci (2014) 0.83
Influence of systemic immune and cytokine responses during the acute phase of zoster on the development of postherpetic neuralgia. J Zhejiang Univ Sci B (2009) 0.82
Spinal NF-κB and chemokine ligand 5 expression during spinal glial cell activation in a neuropathic pain model. PLoS One (2015) 0.80
Preclinical toxicity evaluation of AAV for pain: evidence from human AAV studies and from the pharmacology of analgesic drugs. Mol Pain (2014) 0.80
The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective. Annu Rev Pharmacol Toxicol (2016) 0.80
Spatiotemporal pattern of concurrent spinal and supraspinal NF-κB expression after peripheral nerve injury. J Pain (2010) 0.79
Gene therapy: a potential approach for cancer pain. Pain Res Treat (2011) 0.78
[Cytokines in psychoneuroendocrine immunological context of nonspecific musculoskeletal pain]. Schmerz (2012) 0.76
High cerebrospinal fluid levels of interleukin-10 attained by AAV in dogs. Gene Ther (2014) 0.76
Activation of spinal NF-КB mediates pain behavior induced by plantar incision. Int J Clin Exp Med (2015) 0.75
Intrathecal morphine in mice: a new technique. Eur J Pharmacol (1980) 5.99
The role of neuroinflammation and neuroimmune activation in persistent pain. Pain (2001) 3.15
Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci (1998) 1.99
Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology. Anesth Analg (1989) 1.96
Clinical and pre-clinical pain assessment: are we measuring the same thing? Pain (2008) 1.87
Pain following spinal cord injury: animal models and mechanistic studies. Pain (2000) 1.64
Beneficial effects of modest systemic hypothermia on locomotor function and histopathological damage following contusion-induced spinal cord injury in rats. J Neurosurg (2000) 1.61
Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res (1981) 1.61
Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J Neurosci (2001) 1.50
Chronic pain after spinal injury: interference with sleep and daily activities. Arch Phys Med Rehabil (2001) 1.48
Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. J Pharmacol Exp Ther (1987) 1.42
Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord. J Neurosci (1998) 1.40
The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. J Neurosci (1997) 1.37
The role of nitric oxide in hippocampal long-term potentiation. Neuron (1992) 1.33
Perceived difficulty in dealing with consequences of spinal cord injury. Arch Phys Med Rehabil (1999) 1.30
Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp Neurol (2001) 1.29
Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA. J Neurosci (1991) 1.27
Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci Lett (1992) 1.24
Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain. J Neurosci (2001) 1.24
Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine. J Pharmacol Exp Ther (1999) 1.23
International spinal cord injury pain classification: part I. Background and description. March 6-7, 2009. Spinal Cord (2011) 1.23
Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain (1996) 1.22
Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp Neurol (1999) 1.21
Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain (1997) 1.18
Photochemically induced cerebral infarction. I. Early microvascular alterations. Acta Neuropathol (1987) 1.14
Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci U S A (2000) 1.14
Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp Neurol (1999) 1.10
Neuroprotective effects of basic fibroblast growth factor following spinal cord contusion injury in the rat. J Neurotrauma (1999) 1.09
Differential effects of stress on escape and reflex responses to nociceptive thermal stimuli in the rat. Brain Res (2003) 1.05
Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2. Neuroreport (1997) 1.04
Posttraumatic hypothermia reduces polymorphonuclear leukocyte accumulation following spinal cord injury in rats. J Neurotrauma (2000) 1.04
Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J Pharmacol Exp Ther (1987) 1.03
Apoptotic and anti-apoptotic mechanisms following spinal cord injury. J Neuropathol Exp Neurol (2001) 1.02
Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level. J Pharmacol Exp Ther (1983) 1.00
Mechanisms of induction of persistent nociception by dynorphin. J Pharmacol Exp Ther (2001) 1.00
Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord. Brain Res (1987) 1.00
Intrathecal substance P and somatostatin in rats: behaviors indicative of sensation. Peptides (1982) 0.99
Tumor necrosis factor-alpha enhances interferon-gamma-mediated class II antigen expression on astrocytes. J Neuroimmunol (1989) 0.97
Chronic, selective forebrain responses to excitotoxic dorsal horn injury. Exp Neurol (2000) 0.96
Nociceptive characteristics of tumor necrosis factor-alpha in naive and tumor-bearing mice. Neuroscience (2005) 0.96
International Spinal Cord Injury Pain (ISCIP) Classification: Part 2. Initial validation using vignettes. Spinal Cord (2012) 0.95
An instrument using a multiple layer Peltier device to change skin temperature rapidly. Brain Res Bull (1984) 0.95
Cells of origin of propriospinal connections to cat lumbosacral gray as determined with horseradish peroxidase. Exp Neurol (1980) 0.94
Functional interactions between tumor and peripheral nerve in a model of cancer pain in the mouse. Pain Med (2001) 0.93
Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J Pharmacol Exp Ther (1997) 0.93
Tolerance to morphine analgesia: decreased multiplicative interaction between spinal and supraspinal sites. Brain Res (1984) 0.93
A nitric oxide synthesis inhibitor (L-NAME) reduces licking behavior and Fos-labeling in the spinal cord of rats during formalin-induced inflammation. Pain (1996) 0.93
Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors. J Pharmacol Exp Ther (1992) 0.92
Opioid modulation of reflex versus operant responses following stress in the rat. Neuroscience (2007) 0.92
Phencyclidine selectively blocks a spinal action of N-methyl-D-aspartate in mice. Neurosci Lett (1986) 0.92
Agmatine improves locomotor function and reduces tissue damage following spinal cord injury. Neuroreport (2000) 0.92
Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice. J Pharmacol Exp Ther (1993) 0.90
Effects of peripheral nerve injury on alpha-2A and alpha-2C adrenergic receptor immunoreactivity in the rat spinal cord. Neuroscience (1999) 0.90
Intrathecal serotonin in mice: analgesia and inhibition of a spinal action of substance P. Life Sci (1983) 0.90
Relationships among clinical characteristics of chronic pain after spinal cord injury. Arch Phys Med Rehabil (2001) 0.89
NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord. Brain Res (1997) 0.89
Oestrogen receptor beta contributes to the transient sex difference in tyrosine hydroxylase expression in the mouse locus coeruleus. J Neuroendocrinol (2008) 0.89
Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord. Pain (1990) 0.89
Spinothalamic tract neurons that project to medial and/or lateral thalamic nuclei: evidence for a physiologically novel population of spinal cord neurons. J Neurophysiol (1981) 0.87
Intrathecal opioids block a spinal action of substance P in mice: functional importance of both mu- and delta-receptors. Eur J Pharmacol (1982) 0.87
Analgesic properties of intrathecally administered heterocyclic antidepressants. Pain (1987) 0.87
Conditions affecting the onset, severity, and progression of a spontaneous pain-like behavior after excitotoxic spinal cord injury. J Pain (2001) 0.87
Long-lasting hyperalgesia and sympathetic dysregulation after formalin injection into the rat hind paw. Neuroscience (2008) 0.86
Neurogenesis in postnatal rat spinal cord: a study in primary culture. Science (1997) 0.86
Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice. J Pharmacol Exp Ther (1999) 0.85
NF-κB in the mechanism of brain edema in acute liver failure: studies in transgenic mice. Neurobiol Dis (2010) 0.85
Nitric oxide mediates Fos expression in the spinal cord induced by mechanical noxious stimulation. Neuroreport (1992) 0.85
Inhibition of primate spinothalamic tract neurons by stimulation in ventral posterior lateral (VPLc) thalamic nucleus: possible mechanisms. J Neurophysiol (1983) 0.84
Baclofen, gamma-aminobutyric acidB receptors and substance P in the mouse spinal cord. J Pharmacol Exp Ther (1989) 0.84
Moxonidine, a selective imidazoline-alpha2 -adrenergic receptor agonist, produces spinal synergistic antihyperalgesia with morphine in nerve-injured mice. Anesthesiology (2000) 0.84
Postsynaptic inhibition of primate spinothalamic neurons by stimulation in nucleus raphe magnus. Brain Res (1981) 0.83
Detrimental effects of systemic hyperthermia on locomotor function and histopathological outcome after traumatic spinal cord injury in the rat. Neurosurgery (2001) 0.83
Inhibitory receptive fields of primate spinothalamic tract cells. J Neurophysiol (1981) 0.83
Differential effects of spinal cord lesions on narcotic and non-narcotic suppression of nociceptive reflexes: further evidence for the physiologic multiplicity of pain modulation. Brain Res (1978) 0.82
Effects of adrenal medullary transplants on pain-related behaviors following excitotoxic spinal cord injury. Brain Res (1998) 0.82
A retrograde double label tracing technique using horseradish peroxidase and the fluorescent dye 4'-,6-diamidino-2-phenylindole 2HC1 (DAPI). J Neurosci Methods (1981) 0.82
Functional expression of adrenergic and opioid receptors in Xenopus oocytes: interaction between alpha 2- and beta 2-adrenergic receptors. Brain Res Mol Brain Res (1995) 0.82
Analgesic synergy between opioid and α2 -adrenoceptors. Br J Pharmacol (2014) 0.81
A further examination of effects of cortical stimulation on primate spinothalamic tract cells. J Neurophysiol (1983) 0.81
Muscimol, gamma-aminobutyric acidA receptors and excitatory amino acids in the mouse spinal cord. J Pharmacol Exp Ther (1989) 0.81
Implantation of AtT-20 or genetically modified AtT-20/hENK cells in mouse spinal cord induced antinociception and opioid tolerance. J Neurosci (1994) 0.80
Diffusion-weighted MR imaging in a rat model of syringomyelia after excitotoxic spinal cord injury. AJNR Am J Neuroradiol (1999) 0.80
Spinal plasticity of acute opioid tolerance. J Biomed Sci (2000) 0.80
Inhibition of primate spinothalamic tract neurons by stimulation in ipsilateral or contralateral ventral posterior lateral (VPLc) thalamic nucleus. Brain Res (1981) 0.80
Inhibition of primate spinothalamic tract neurons by stimulation in periaqueductal gray or adjacent midbrain reticular formation. J Neurophysiol (1984) 0.79
Enhancement of NMDA-evoked neuronal activity by glycine in the rat spinal cord in vivo. Neurosci Lett (1992) 0.79
Immunofluorescence analysis of antisense oligodeoxynucleotide-mediated 'knock-down' of the mouse delta opioid receptor in vitro and in vivo. Neurosci Lett (1996) 0.79
Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice. J Pharmacol Exp Ther (1991) 0.79
Modeling motor cortical operations by an attractor network of stochastic neurons. Biol Cybern (1996) 0.79
Intrathecal 5-methoxy-N,N-dimethyltryptamine in mice modulates 5-HT1 and 5-HT3 receptors. Eur J Pharmacol (1993) 0.79
Intradermal hypertonic saline-induced behavior as a nociceptive test in mice. Life Sci (1986) 0.78
Midbrain nuclei projecting to the medial medulla oblongata in the monkey. J Comp Neurol (1983) 0.78
Cross-correlation analysis of connectivities among cat lumbosacral dorsal horn cells. J Neurophysiol (1979) 0.78
The effects of serotonin antagonists on the inhibition of primate spinothalamic tract cells produced by stimulation in nucleus raphe magnus or periaqueductal gray. J Pharmacol Exp Ther (1982) 0.78
Cells of origin of the spinoreticular tract in the monkey. J Comp Neurol (1982) 0.78